Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Dec 23:12:783439.
doi: 10.3389/fendo.2021.783439. eCollection 2021.

Risk Factors for Subacute Thyroiditis Recurrence: A Systematic Review and Meta-Analysis of Cohort Studies

Affiliations
Meta-Analysis

Risk Factors for Subacute Thyroiditis Recurrence: A Systematic Review and Meta-Analysis of Cohort Studies

Jing Zhang et al. Front Endocrinol (Lausanne). .

Abstract

Background: Subacute thyroiditis (SAT) is a self-limited inflammatory thyroid disease with recurring episodes. However, the results regarding the recurrence rate and risk factors for SAT are inconsistent. This meta-analysis aimed to summarize the evidence of the recurrence rate and the risk factors for SAT.

Methods: The present study involved the performance of a systematic literature search of all English studies published in PubMed, Embase, Web of Science, and The Cochrane Library from inception to August 20, 2021. Cohort studies that reported the SAT recurrence rate and risk factors for recurrence were included. Two independent investigators extracted relevant information. Fixed- and random-effects models were used to pool effect sizes based on study heterogeneity.

Results: Eighteen cohort studies were identified. The pooled findings showed that the recurrence rate was 12.0% (95% CI: 8.2%, 17.1%). The risk of recurrence in the glucocorticoids group was higher than that in the NSAIDs group (RR = 1.84, 95% CI: 1.04, 3.24). However, there was no significant difference in age or sex between the recurrence group and the non-recurrence group. Findings from one or two cohort studies also indicated that the copresence of HLA-B*18:01 and -B*35, the number of days required to taper prednisolone (PSL) to 5 mg/day, the duration of disease before treatment less than 30 days, the sialic acid level, or the TSH level at the termination of treatment and further extension of the hypoechoic area and increase in thyroid volume were related to the recurrence of SAT.

Conclusion: Recurrence was common in SAT patients. The present study indicated that glucocorticoid treatment was associated with a higher recurrence rate of SAT than NSAIDs treatment. The clinical implications of this association should be interpreted with caution, and further clinical trials on the long-term effects of different treatment strategies are needed.

Keywords: cohort study; meta-analysis; recurrence rate; risk factors; subacute thyroiditis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram for the selection of the included studies.
Figure 2
Figure 2
Forest plot of SAT recurrence rate and the association between factors and subacute thyroiditis (SAT) recurrence. (A) recurrence rate. (B) age. (C) sex. (D) treatment (glucocorticoids/NSAIDs). 95% CI, confidence interval.
Figure 3
Figure 3
Funnel plots of the SAT recurrence rate and risk factors. (A) recurrence rate. (B) age. (C) sex. (D) treatment (glucocorticoids/NSAIDs).

References

    1. Jameson JL, Mandel SJ, Weetman AP. Disorders of the Thyroid Gland. In: Kasper D, Fauci A, Hauser S, editors. Harrisons Principles of Internal Medicine. 2. 19th Ed. New York: McGraw Hill Education/Medical; (2015). p. 2298.
    1. Effraimidis G, Feldt-Rasmussen U. Thyroiditis, Infectious and Subacute. In: Huhtaniemi I, Luciano Martini L, editors. Encyclopedia of Endocrine Diseases. 4. 2 Ed. The United StatesElsevier-Saunders; (2018). p. 737–45.
    1. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med (2003) 348:2646–55. doi: 10.1056/NEJMra021194 - DOI - PubMed
    1. Crile G, Rumsey E. Subacute Thyroiditis. J Am Med Assoc (1950) 142:458–62. doi: 10.1001/jama.1950.02910250006002 - DOI - PubMed
    1. Alfadda AA, Sallam RM, Elawad GE, Aldhukair H, Alyahya MM. Subacute Thyroiditis: Clinical Presentation and Long Term Outcome. Int J Endocrinol (2014) 2014:794943. doi: 10.1155/2014/794943 - DOI - PMC - PubMed

Publication types

LinkOut - more resources